FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+22.03%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$13B
AUM Growth
+$13B
(+6.2%)
Cap. Flow
-$1.73B
Cap. Flow
% of AUM
-13.34%
Top 10 Holdings %
Top 10 Hldgs %
41.93%
Holding
132
New
29
Increased
37
Reduced
29
Closed
15
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$336M |
| 2 |
MDCO
Medicines Co
MDCO
|
$282M |
| 3 |
Salesforce
CRM
|
$281M |
| 4 |
Thermo Fisher Scientific
TMO
|
$277M |
| 5 |
IAC Inc
IAC
|
$152M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$1.55B |
| 2 |
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
|
$865M |
| 3 |
AABA
Altaba Inc. Common Stock
AABA
|
$666M |
| 4 |
Alibaba
BABA
|
$221M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
$183M |
Sector Composition
| 1 | Healthcare | 43.93% |
| 2 | Communication Services | 12.69% |
| 3 | Technology | 11.19% |
| 4 | Industrials | 5.73% |
| 5 | Financials | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
CRISPR Therapeutics
CRSP
$4.82B
| $21.3M | 0.14% |
350,000
-210,367
| -38% | -$12.8M |
|
|
WMGI
77
DELISTED
Wright Medical Group Inc
WMGI
| $21M | 0.14% |
+690,000
| New | +$21M |
|
78
Heron Therapeutics
HRTX
$204M
| $20.6M | 0.14% |
+875,000
| New | +$20.6M |
|
|
CY
79
DELISTED
Cypress Semiconductor
CY
| $19.6M | 0.13% |
840,000
-1,624,966
| -66% | -$37.9M |
|
80
Gen Digital
GEN
$18.3B
| $18.4M | 0.12% |
720,000
-310,000
| -30% | -$7.91M |
|
|
S
81
DELISTED
Sprint Corporation
S
| $16.7M | 0.11% |
3,200,000
-3,034,186
| -49% | -$15.8M |
|
|
EIGR
82
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $16.3M | 0.11% |
1,094,559
-30,441
| -3% | -$454K |
|
83
Pacific Biosciences
PACB
$378M
| $15.4M | 0.1% |
+3,000,000
| New | +$15.4M |
|
|
RETA
84
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $15.3M | 0.1% |
75,000
-107,060
| -59% | -$21.9M |
|
85
Apellis Pharmaceuticals
APLS
$3.51B
| $15.3M | 0.1% |
+500,000
| New | +$15.3M |
|
|
LVGO
86
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $15M | 0.1% |
+600,000
| New | +$15M |
|
87
Exagen
XGN
$213M
| $14.7M | 0.1% |
577,699
+214,363
| +59% | +$5.44M |
|
88
uniQure
QURE
$954M
| $14.3M | 0.1% |
200,000
+99,078
| +98% | +$7.1M |
|
|
LOGM
89
DELISTED
LogMein, Inc.
LOGM
| $11.2M | 0.08% |
+130,241
| New | +$11.2M |
|
90
Protagonist Therapeutics
PTGX
$3.62B
| $10.6M | 0.07% |
1,500,000
| – | – |
|
|
OPTN
91
DELISTED
OptiNose
OPTN
| $8.3M | 0.06% |
+900,000
| New | +$8.3M |
|
92
Rocket Pharmaceuticals
RCKT
$358M
| $8.06M | 0.05% |
+354,082
| New | +$8.06M |
|
|
GCVRZ
93
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $7.91M | 0.05% |
9,195,584
+2,367,779
| +35% | +$2.04M |
|
94
Gossamer Bio
GOSS
$587M
| $7.82M | 0.05% |
500,000
+399,288
| +396% | +$6.24M |
|
|
DMTK
95
DELISTED
DermTech, Inc. Common Stock
DMTK
| $7.63M | 0.05% |
615,385
| – | – |
|
96
Abeona Therapeutics
ABEO
$356M
| $6.54M | 0.04% |
+2,000,000
| New | +$6.54M |
|
97
Arrowhead Research
ARWR
$3.84B
| $6.34M | 0.04% |
100,000
-550,000
| -85% | -$34.9M |
|
|
PHAS
98
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $6.11M | 0.04% |
1,000,000
+192,072
| +24% | +$1.17M |
|
|
OYST
99
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $5.64M | 0.04% |
+230,800
| New | +$5.64M |
|
100
Atara Biotherapeutics
ATRA
$88.7M
| $5.51M | 0.04% |
+334,706
| New | +$5.51M |
|